PHIO — Phio Pharmaceuticals Corp.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1533040 ·
Last close
$1.08
Market Cap
$12.55M
52W High
$1.35
52W Low
$0.98
ADV30
139,691
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -4,167,000 | -4,003,000 | 17,412,000 | 17,031,000 | 950,000 |
| Dec 2025 | 0 | — | -2,534,000 | -2,371,000 | 21,487,000 | 21,031,000 | 1,340,000 |
| Sep 2025 | 0 | — | -2,505,000 | -2,392,000 | 11,505,000 | 10,705,000 | 1,666,000 |
| Jun 2025 | 0 | — | -2,309,000 | -2,166,000 | 11,301,000 | 10,775,000 | 1,206,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,979,000
Investing CF
$-12,000
Financing CF
$23,640,000
CapEx
$-12,000
Dividends Paid
—
Buybacks
$-1,000
EPS Diluted TTM
$-2.84
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-155,054,000
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-9,220,000
Pretax Income TTM
$-8,698,000
Interest Exp TTM
—
Analysts
1
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -9,220,000 | -8,698,000 | 21,487,000 | 1,340,000 | — | -7,979,000 |
| Dec 2024 | 0 | -7,387,000 | -7,150,000 | 5,738,000 | 1,015,000 | — | -7,112,000 |
| Dec 2023 | 0 | -10,698,000 | -10,826,000 | 9,364,000 | 1,634,000 | — | -10,749,000 |
| Dec 2022 | 0 | -11,462,000 | -11,480,000 | 12,814,000 | 1,976,000 | — | -12,129,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.86
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BIOE | Bio Essence Corp | $12.83M | $0.27 | — |
| GOVX | GeoVax Labs, Inc. | $12.12M | $3.49 | — |
| MBRX | Moleculin Biotech, Inc. | $13.07M | $2.45 | — |
| CALC | CalciMedica, Inc. | $12.01M | $0.76 | — |
| BFRG | BullFrog AI Holdings, Inc. | $13.13M | $0.71 | — |
News headlines (Yahoo Finance, 1h cache)
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
2026-05-26 11:00 · Yahoo
Phio Pharmaceuticals Announces "Innovations in Skin Cancer Treatment and Prevention" in a Fireside Chat with Force Family Office on Tuesday, May 19, 2026
2026-05-12 11:00 · Yahoo
Phio Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update
2026-05-07 20:05 · Yahoo
Phio Pharmaceuticals Announces "Nobel Prize Winning Science Takes on Skin Cancer" in a Fireside Chat with Force Family Office on Wednesday, April 15, 2026
2026-04-13 11:00 · Yahoo
Phio Pharmaceuticals Announces Presentation at Centri Capital Conference on April 14, 2026
2026-04-09 11:00 · Yahoo
Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762
2026-03-30 11:00 · Yahoo
Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancemen
2026-03-23 11:00 · Yahoo
Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office
2026-03-16 15:30 · Yahoo
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
2026-03-13 12:35 · Yahoo
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
2026-03-10 14:21 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.